OpGen

Op Gen

Biotechnology, 9717 Key West Ave, Rockville, Maryland, 20850, United States, 51-200 Employees

opgen.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 13*********

Who is OPGEN

Mission We harness the power of molecular microbiology and bioinformatics to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. ...

Read More

map
  • 9717 Key West Ave, Rockville, Maryland, 20850, United States Headquarters: 9717 Key West Ave, Rockville, Maryland, 20850, United States
  • 2002 Date Founded: 2002
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541713 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OPGEN

OpGen Org Chart and Mapping

Employees

Richard Uhlenbrock

Director, Business Development - Central Us

Barbara S

Molecular Biologist Iii-Assay Development/Health & Safety Officer

Theo Devos

Senior VP Corporate Development & Operations

Eric Greenbank

Qc Laboratory Technician

Luis Rivera

Production & Fulfilment Technician

Christine Cornell

Accounting Manager, Intercompany Specialist

Martha Martin

Technical Applications Specialist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding OpGen

Answer: OpGen's headquarters are located at 9717 Key West Ave, Rockville, Maryland, 20850, United States

Answer: OpGen's phone number is 13*********

Answer: OpGen's official website is https://opgen.com

Answer: OpGen's revenue is $50 Million to $100 Million

Answer: OpGen's SIC: 8731

Answer: OpGen's NAICS: 541713

Answer: OpGen has 51-200 employees

Answer: OpGen is in Biotechnology

Answer: OpGen contact info: Phone number: 13********* Website: https://opgen.com

Answer: Mission We harness the power of molecular microbiology and bioinformatics to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and help improve antibiotic stewardship. About Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access